In conclusion, our results indicate that CACHD1 is an early NASH-associated biomarker of liver preneoplastic lesions and tumors in STAM mice NASH model which could be applied to investigate the mechanisms and potential inhibitors or promoters of DM/NASH-associated hepatocarcinogenesis in this animal model. Here, CACHD1 is linked to metabolic dysfunction-associated steatohepatitis.